Harnessing immune cells' adaptability to design an effective HIV vaccine
2013-03-21
(Press-News.org) In infected individuals, HIV mutates rapidly to escape recognition by immune cells. This process of continuous evolution is the main obstacle to natural immunity and the development of an effective vaccine. A new study published by Cell Press in the March 21 issue of the journal Immunity reveals that the immune system has the capacity to adapt such that it can recognize mutations in HIV. The findings suggest that our immune cells' adaptability could be harnessed to help in the fight against AIDS.
An international collaboration between research groups in France, England, Japan, and Australia discovered that immune cells from certain infected individuals were able to recognize HIV mutants. Researchers found that the immune cells' ability to recognize such mutant forms of the virus was associated with a protective response against HIV. This discovery begs the question: if mutant HIV can be recognized by immune cells, how then does HIV often escape immune detection? The researchers explain that the answer lies in HIV's ability to conceal itself from immune surveillance altogether. It does so by blocking infected cells from breaking down its viral particles and from then displaying them on the cells' surface to alert the immune system.
"Using a spectrum of advanced immune profiling techniques, our work illustrates the sophisticated mechanisms that underlie the continuous competition, or 'molecular arms race,' between immune cells and HIV," says senior author Dr. Victor Appay, of Hôpital Pitié-Salpêtrière in Paris. "Overall, our study reveals the intricacies of immune cell efficacy against HIV."
Although immune cells not be able to recognize every mutant HIV, a vaccine that stimulates immune cells that recognize certain key mutant forms of the virus may be effective against viral infection and the development of AIDS.
###
Immunity, Ladell et al.: "A molecular basis for the control of pre-immune escape variants by HIV-specific CD8+ T-cells." END
ELSE PRESS RELEASES FROM THIS DATE:
2013-03-21
PHILADELPHIA — Scientists have characterized how the functionality of genetically engineered T cells administered therapeutically to patients with melanoma changed over time. The data, which are published in Cancer Discovery, a journal of the American Association for Cancer Research, highlight the need for new strategies to sustain antitumor T cell functionality to increase the effectiveness of this immunotherapeutic approach.
Early clinical research has indicated that cell-based immunotherapies for cancer, in particular melanoma, have potential because patients treated ...
2013-03-21
Seventy-five percent of the world's population consumes nearly twice the daily recommended amount of sodium (salt), according to research presented at the American Heart Association's Nutrition, Physical Activity and Metabolism and Cardiovascular Disease Epidemiology and Prevention 2013 Scientific Sessions.
Global sodium intake from commercially prepared food, table salt, salt and soy sauce added during cooking averaged nearly 4,000 mg a day in 2010.
The World Health Organization recommends limiting sodium to less than 2,000 mg a day and the American Heart Association ...
2013-03-21
Researchers from the RIKEN Advanced Science Institute and Nippon Medical School in Japan have identified a protein likely to be involved in the exacerbation of chronic obstructive pulmonary disease (COPD). This protein, Siglec-14, could serve as a potential new target for the treatment of COPD exacerbation.
In a study published today in the journal Cellular and Molecular Life Sciences the researchers show that COPD patients who do not express Siglec-14, a glycan-recognition protein, are less susceptible to exacerbation compared with those who do.
COPD is a chronic ...
2013-03-21
JUPITER, FL – March 21, 2013 – Researchers at The Scripps Research Institute (TSRI) in Jupiter, FL, have developed cutting-edge technology that can successfully screen human blood for disease markers. This tool may hold the key to better diagnosing and understanding today's most pressing and puzzling health conditions, including autoimmune diseases.
"This study validates that the 'antigen surrogate' technology will indeed be a powerful tool for diagnostics," said Thomas Kodadek, PhD, a professor in the Departments of Chemistry and Cancer Biology and vice chairman of ...
2013-03-21
(Boston) – Researchers at Boston University School of Medicine (BUSM) have identified a new chemical class of compounds that have the potential to block genetically diverse viruses from replicating. The findings, published in Chemistry & Biology, could allow for the development of broad-spectrum antiviral medications to treat a number of viruses, including the highly pathogenic Ebola and Marburg viruses.
Claire Marie Filone, PhD, postdoctoral researcher at BUSM and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), is the paper's first ...
2013-03-21
The American College of Medical Genetics and Genomics (ACMG) released the widely-anticipated "ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing" report at its 2013 Annual Clinical Genetics Meeting today in Phoenix. The ACMG Annual Clinical Genetics Meeting is one of the largest gatherings of medical and health professionals in genetics in the world.
As exome and genome sequencing become more commonly used in medical care, doctors will increasingly be able to learn about genetic changes that increase an individual's risk ...
2013-03-21
NEW YORK – Depressive symptoms after heart disease are associated with a markedly increased risk of death or another heart attack. However, less has been known about whether treating heart attack survivors for depressive symptoms could relieve these symptoms, be cost-effective, and ultimately, reduce medical risk? Columbia University Medical Center's Karina W. Davidson, PhD and her research team now report a patient-centered approach that answers these questions in the affirmative.
With a grant from the National Institutes of Health's National Heart, Lung, and Blood Institute ...
2013-03-21
TORONTO, March 21, 2013—Homeless people and their health care providers need to know more about traumatic brain injuries to help prevent and treat such injuries, a new study has found.
Homeless people have a disproportionately higher risk for TBI compared to the general population, yet little is known about the severity of those injuries, who exactly is suffering from them and what the long-term consequences are.
"A better understanding of TBI, its presentation and characteristics in the homeless is vital in order to enable appropriate interventions, treatments, and ...
2013-03-21
A dysfunction of a certain Calcium channel, the so called P/Q-type channel, in neurons of the cerebellum is sufficient to cause different motor diseases as well as a special type of epilepsy. This is reported by the research team of Dr. Melanie Mark and Prof. Dr. Stefan Herlitze from the Ruhr-Universität Bochum. They investigated mice that lacked the ion channel of the P/Q-type in the modulatory input neurons of the cerebellum. "We expect that our results will contribute to the development of treatments for in particular children and young adults suffering from absence ...
2013-03-21
PROVIDENCE, R.I. [Brown University] — A new study finds that two genes individually associated with rare autism-related disorders are also jointly linked to more general forms of autism. The finding suggests a new genetic pathway to investigate in general autism research.
The genes encode the proteins NHE6 and NHE9, which are responsible for biochemical exchanges in the endosomes of cells. Mutations in the NHE6 gene are a direct cause of Christianson Syndrome, while mutations in the NHE9 gene lead to a severe form of autism with epilepsy. In the new study, a statistical ...
LAST 30 PRESS RELEASES:
[Press-News.org] Harnessing immune cells' adaptability to design an effective HIV vaccine
